This is an alert regarding the ImmunoCARE Study. The U.S. Food and Drug Administration (FDA) issued a communication to recommend that patients, caregivers, and health care providers do not use Cue Health’s COVID-19 Tests due to an increased risk of false results. 

We are determining next steps for the ImmunoCARE Study. In the meantime, please discontinue use of your Cue Health tests. We thank you for your participation and apologize for any inconvenience this may cause. 

Take Care,

The ImmunoCARE Study Team

Questions? Reach out to us at Immunocare@scripps.edu